L-Citrulline in Patients With Post-Polio Syndrome
NCT02801071
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Post-Polio Syndrome
Interventions
DRUG:
15g L-citrulline daily p.o.
DRUG:
Placebo
Sponsor
Dirk Fischer